Recent Updates
Recently added Catalysts

Dynavax Technologies Corporation

DVAXFDA catalysts, PDUFA dates & pipeline intelligence
$15.5
▲ +0.01 · +0.06%

Last traded Feb 9, 2026. This price is not current.

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full DVAX financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $9.2052W HIGH $15.73
Volume
7.11 M
Value Traded
110.13 M
Short % Float
8.69%
Days to Cover
5.2
+0.13%Week
+0.52%1 Month
+40.27%3 Month
+45.54%6 Month
+44.86%5 Year
-81.87%All Time

Cash Data

Unlock DVAX cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
1.82 B
EPS (TTM)
-0.33
P/E Ratio
-
Ent. Value
1.46 B
Total Shares
117.28 M
Float Shares
112.71 M
Insiders
0.81%
Institutions
97.03%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Phase 1/2 data readout
Z-1018
Shingles (prevention in adults aged 50 years and older)
Phase 1/2VaccinesInfectious Diseases
Unlock every DVAX catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

DVAX Catalyst Timeline

Dated clinical, regulatory and corporate events for Dynavax Technologies Corporation

Unlock the full DVAX catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How DVAX actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
2024-05-01HEPLISAV-B (four-dose regimen) sBLA PDUFA Date CRLPDUFA
Unlock 2 more DVAX historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

Pipeline Score
Pipeline Value
Commercial Value
Valuation Signal
2
Drugs Scored
rNPV / MCap
Top Drug
Commercial products (revenue basis: trailing 4 quarters of total revenue (10-K and 10-Q), to Sep 2025; product lines: last four quarters to Sep 2025 (10-K and 10-Q))
ProductRevenuePrior periodChange
HEPLISAVB
Showing 8 of 17 assets
DrugIndicationPhasePTRSrNPVStatusEnrollVelocityDesignEst. CompletionML SignalLast Change
rF1V-1018 Monoclonal antibodyNCT07207408Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia PestisPhase 2 ACTIVE NOT_RECRUITING 148Aug 31, 2027
Z-1018 Monoclonal antibodyNCT06569823ShinglesPhase 1/2 ACTIVE NOT_RECRUITING 914Jun 1, 2027
rF1V-1018 Monoclonal antibodyCompletedNCT05506969Plague, PneumonicPhase 2 COMPLETED 200Apr 26, 2024
HEPLISAV Monoclonal antibodyNot countedNCT01999699Hepatitis BPhase 3 COMPLETED 2,660Mar 1, 2015
HEPLISAV-B Monoclonal antibodyNot countedNCT04193189HIV InfectionPhase 3 COMPLETED 638Aug 13, 2024
HEPLISAV-B Monoclonal antibodyNot countedNCT00985426Chronic Kidney DiseasePhase 3 COMPLETED 521Jan 1, 2012
HEPLISAV Monoclonal antibodyNot countedNCT01195246End Stage Renal DiseasePhase 3 COMPLETED 155Aug 1, 2012
HEPLISAV-B Small moleculeNot countedNCT03934736End Stage Renal Disease on Hemodialysis (Diagnosis)Phase 1 COMPLETED 119Sep 15, 2021
Unlock the DVAX pipeline intelligence model
PTRS, rNPV, enrollment velocity, trial design quality and ML risk signals for every asset above.
Institutional-grade data · Cancel anytime

Clinical Trial Results

Readouts, endpoints and source filings for every DVAX program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Z-1018 shinglesPhase 1/22025-10-21Part 1 of the Phase 1/2 trial demonstrated favorable safety and immunogenicity profiles.Read MoreDynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of TrialRead More
Scroll for more · summaries link to the source press release
Unlock every DVAX trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock DVAX insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Novack David FOfficer (President & COO)Option 20,000 83,344 held$6.81 01/15/2026
Unlock the full DVAX insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Hedge Funds invested in DVAX

Fund % of Portfolio Current MV Shares Owned Activity
Deep Track Capital, LP 4.3 % (-2.3 %) 241.87 M 15.73 M
Unlock every fund holding DVAX
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in DVAX
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see DVAX ownership
Insider and institutional ownership, quarter by quarter.

DVAX Short Interest

Shares sold short, counted twice a month.

8.69%
Short % of Float
of tradable shares sold short
9.8M
Shares Sold Short
+7.3% vs prior count
5.2 High
Days to Cover
trading days of normal volume to buy every short share back
1.9M
Avg Daily Volume
the average used for days to cover
Unlock DVAX short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
Unlock DVAX option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live DVAX option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock DVAX options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How DVAX ranks across every disease it competes in

Competitive Position is a premium feature
See how DVAX ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

DVAX News

About Dynavax Technologies Corporation

Founded1996
BIOPHARMAWATCH ELITE PLUS
Trade the next DVAX catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime